Evidence map›Paper›PMID 20225011›Full record

ReviewCurrent topics in microbiology and immunology2010

VZV infection of keratinocytes: production of cell-free infectious virions in vivo.

Michael D Gershon, Anne A Gershon

Abstract readReview
In one paragraph

Review in Current topics in microbiology and immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 34 citations in OpenAlex.

  1. Varicella zoster virus infection.Nature reviews. Disease primers · 2026
    Review
  2. Article
  3. Review
  4. The host mannose-6-phosphate pathway and viral infection.Frontiers in cellular and infection microbiology · 2024
    Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Kallikreins emerge as new regulators of viral infections.Cellular and molecular life sciences : CMLS · 2021
    Review
  10. Article
  11. Article
  12. TheJournal of virology · 2019
    Article
  13. Article
  14. Varicella-Zoster Virus and the Enteric Nervous System.The Journal of infectious diseases · 2018
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. THE JEREMIAH METZGER LECTURE VARICELLA ZOSTER VIRUS: FROM OUTSIDE TO INSIDE.Transactions of the American Clinical and Climatological Association · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Michael D GershonDepartment of Pathology and Cell Biology, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA. mdg4@columbia.edu
Anne A Gershon
Columbia University · US

Funding

VZV in the enteric nervous system: pathogenesis and consequencesR01DK093094 · NIDDK · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MICHAEL D GERSHON, Anne A. Gershon · 2011 to 2026
$5.9M
NEURAL CONTROL OF GASTROINTESTINAL ACTIVITYR01NS012969 · NINDS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI GERSHON, MICHAEL D · 1985 to 2012
$5.3M
VZ VIRUS: CLINICAL IMPLICATIONS OF IMMUNITYR01AI024021 · NIAID · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI SILVERSTEIN, SAUL J · 1986 to 2008
$3.0M
VZV Receptors and Infective MechanismsR01AI027187 · NIAID · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI GERSHON, ANNE A. · 1990 to 2007
$2.4M
Varicella Zoster Virus:Clinical Implications of ImmunityR21AI024021 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SILVERSTEIN, SAUL J · 2003 to 2003
$363k
VZV Receptors &Infective MechanismsR21AI027187 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GERSHON, ANNE A. · 2001 to 2001
$327k
NIAID NIH HHS AI24021NIAID NIH HHS AI27187NIAID NIH HHS R01 AI024021NIAID NIH HHS R01 AI027187NIAID NIH HHS R21 AI024021NIAID NIH HHS R21 AI027187NIDDK NIH HHS R01 DK093094NINDS NIH HHS NS12969NINDS NIH HHS R01 NS012969
6 · The paper itself

Abstract

Varicella-zoster virus (VZV) is the cause of varicella (chickenpox) and zoster (shingles). Varicella is a primary infection that spreads rapidly in epidemics while zoster is a secondary infection that occurs sporadically as a result of the reactivation of previously acquired VZV. Reactivation is made possible by the establishment of latency during the initial episode of varicella. The signature lesions of both varicella and zoster are cutaneous vesicles, which are filled with a clear fluid that is rich in infectious viral particles. It has been postulated that the skin is the critical organ in which both host-to-host transmission of VZV and the infection of neurons to establish latency occur. This hypothesis is built on evidence that the large cation-independent mannose 6-phosphate receptor (MPR(ci)) interacts with VZV in virtually all infected cells, except those of the suprabasal epidermis, in a way that prevents the release of infectious viral particles. Specifically, the virus is diverted in an MPR(ci)-dependent manner from the secretory pathway to late endosomes where VZV is degraded. Because nonepidermal cells are thus prevented from releasing infectious VZV, a slow process, possibly involving fusion of infected cells with their neighbors, becomes the means by which VZV is disseminated. In the epidermis, however, the maturation of keratinocytes to give rise to corneocytes in the suprabasal epidermis is associated uniquely with a downregulation of the MPR(ci). As a result, the diversion of VZV to late endosomes does not occur in the suprabasal epidermis where vesicular lesions occur. The formation of the waterproof, chemically resistant barrier of the epidermis, however, requires that constitutive secretion outlast the downregulation of the endosomal pathway. Infectious VZV is therefore secreted by default, accounting for the presence of infectious virions in vesicular fluid. Sloughing of corneocytes, aided by scratching, then aerosolizes the virus, which can float with dust to be inhaled by susceptible hosts. Infectious virions also bathe the terminals of those sensory neurons that innervate the epidermis. These terminals become infected with VZV and provide a route, retrograde transport, which can conduct VZV to cranial nerve (CNG), dorsal root ganglia (DRG), and enteric ganglia (EG) to establish latency. Reactivation returns VZV to the skin, now via anterograde transport in axons, to cause the lesions of zoster. Evidence in support of these hypotheses includes observations of the VZV-infected human epidermis and studies of guinea pig neurons in an in vitro model system.

Indexed as

AnimalsChickenpoxHerpesvirus 3, HumanHerpes ZosterHost-Pathogen InteractionsHumansKeratinocytesVirionVirus LatencyVirus Replication

Identifiers

PMID20225011
PMCPMC5408736
OpenAlexW150515821

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.